{"CONCEPT_ID":[734354],"CDM_TABLE_NAME":["DRUG_ERA"],"CONCEPT_NAME":["pregabalin"],"NUM_PERSONS":[1],"PERCENT_PERSONS":["0.0008"],"RECORDS_PER_PERSON":[" 1.0"],"AGE_AT_FIRST_EXPOSURE":[{"CATEGORY":"FEMALE","MIN_VALUE":50,"P10_VALUE":50,"P25_VALUE":50,"MEDIAN_VALUE":50,"P75_VALUE":50,"P90_VALUE":50,"MAX_VALUE":50}],"PREVALENCE_BY_GENDER_AGE_YEAR":[{"TRELLIS_NAME":"50-59","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":2019,"Y_PREVALENCE_1000PP":13.3333}],"PREVALENCE_BY_MONTH":[{"X_CALENDAR_MONTH":201903,"Y_PREVALENCE_1000PP":0.9785}],"LENGTH_OF_ERA":[{"CATEGORY":"Length of Era","MIN_VALUE":30,"P10_VALUE":30,"P25_VALUE":30,"MEDIAN_VALUE":30,"P75_VALUE":30,"P90_VALUE":30,"MAX_VALUE":30}]}
